Visceral Adiposity Index as an Independent Marker of Subclinical Atherosclerosis in Individuals Prone to Diabetes Mellitus

Journal of Atherosclerosis and Thrombosis
Elko RandrianarisoaKilian Rittig

Abstract

The visceral adiposity index (VAI) has been proposed as an estimate of visceral adipose tissue (VAT) mass and as an indicator of VAT dysfunction. Both parameters are associated with cardiometabolic risk, including insulin resistance. In this study, we investigated whether VAI is associated with subclinical atherosclerosis in subjects who were free of cardiovascular disease but were at risk of developing diabetes mellitus. A total of 731 adults with a median age of 47 years old without diabetes mellitus were included in this cross-sectional study. The anthropometric data, blood pressure, and lipid profiles of 398 women and 333 men were measured. All subjects underwent an oral glucose tolerance test, and carotid intima-media thickness (cIMT) was evaluated by ultrasound. Insulin resistance was estimated using the homeostatic model assessment of insulin resistance (HOMA-IR). VAI and HOMA-IR (ßst=0.44, p<0.0001), VAI and cIMT (ßst=0.17, p<0.0001), and HOMA-IR and cIMT (ßst=0.09, p=0.0127) were correlated with each other. After adjusting for cofounding variables, VAI is still correlated with HOMA-IR (ßst=0.42, p<0.0001). Furthermore, VAI (ßst=0.07, p=0.0392) but not HOMA-IR (ßst=0.03, p=0.37) was correlated with cIMT independently of...Continue Reading

References

Nov 1, 1994·Journal of Internal Medicine·D E Grobbee, M L Bots
Mar 1, 1997·Stroke; a Journal of Cerebral Circulation·S D KantersJ D Banga
Mar 28, 2003·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B L WajchenbergR F Santos
Dec 17, 2003·Hypertension·Christian FoerchMatthias Sitzer
Feb 27, 2004·The American Journal of Clinical Nutrition·Ian JanssenRobert Ross
May 10, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K G M M AlbertiJ Shaw
Dec 15, 2006·Nature·Jean-Pierre Després, Isabelle Lemieux
Aug 13, 2008·Archives of Internal Medicine·Norbert StefanHans-Ulrich Häring
Dec 2, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Alain SimonGilles Chironi
Mar 5, 2010·The New England Journal of Medicine·Elizabeth SelvinFrederick L Brancati
Jul 27, 2011·Diabetes·Norbert Stefan, Hans-Ulrich Häring
Aug 15, 2012·The Canadian Journal of Cardiology·Jean-Pierre Després
Nov 15, 2012·Nature Reviews. Cardiology·Mohamed HassanMagdi Yacoub
Dec 26, 2012·Angiology·Mariusz StepienJacek Rysz
Jun 4, 2013·Journal of the American College of Cardiology·Omair YousufMatthew J Budoff
Jun 22, 2013·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·M C Amato, C Giordano
Mar 26, 2014·Nature Reviews. Endocrinology·Markku Laakso, Johanna Kuusisto
May 16, 2014·International Journal of Endocrinology·Marco Calogero Amato, Carla Giordano
Nov 5, 2014·Nature Reviews. Endocrinology·Fredrik Karpe, Katherine E Pinnick
Oct 31, 2015·VASA. Zeitschrift für Gefässkrankheiten·Elko RandrianarisoaBernd Balletshofer
May 18, 2016·The Lancet. Diabetes & Endocrinology·Norbert StefanHans-Ulrich Häring
Aug 3, 2017·Cell Metabolism·Norbert StefanHans-Ulrich Häring

❮ Previous
Next ❯

Citations

Sep 13, 2019·The Journal of Clinical Endocrinology and Metabolism·Elko RandrianarisoaHarald Staiger
Aug 28, 2020·Metabolic Syndrome and Related Disorders·Sebastião Freitas de MedeirosMárcia Marly Winck Yamamoto
Sep 9, 2020·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Yao YuYi Yang
May 21, 2021·Journal of Atherosclerosis and Thrombosis·Nobuo SasakiYukihito Higashi

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging techniques

Software Mentioned

ESAOTE BIOMEDICA
JMP

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.